|
|
 |
|
Viewing report
|
|
|
|
U.S. Inflammatory Diseases Drug Delivery: Physician Perspective
Frost & Sullivan, Nov 2010, Pages: 45
This study encompasses feedback provided by U.S. physicians who treat inflammatory diseases on aspects of drug delivery and drug treatment, enabling interested stakeholders to gain insight into current and future trends. Analysis includes issues such as awareness, usage, preferences, influencing criteria, patient compliance, desired delivery types to be made available, as well as feedback on the role the device plays in the prescribing decision for a drug.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
2008 U.S. Inflammatory Diseases Drug Delivery: Physician Perspective
U.S. Inflammatory Disease Drug Delivery - Patient Perspective
2008 U.S. Drug Delivery: Neurological Disorders - Physician Perspective
U.S. Diabetes Drug Delivery - Physician Perspective
2008 U.S. Diabetes Drug Delivery - Patient Perspective
2008 U.S. Chronic Pain Drug Delivery: Patient Perspective
Needle Array Drug Delivery Systems: Devices, Therapeutic Markets, Strategies and Prospects
Stakeholder Insight: Major Depressive Disorder - Gaining traction among physicians is crucial in an SSRI-dominated market
Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management
Drug Self-Administration Markets to 2016
|
|
|
|
